Skip to main content
NC3Rs: National Centre for the Replacement Refinement & Reduction of Animals in Research
Webinar and video

The impact of 3Rs approaches on quality control and batch release testing of biologicals

The NC3Rs is working with the World Health Organization (WHO) to review animal testing requirements within their guidelines for the quality control and batch release testing of biologicals. Co-funded by the Bill and Melinda Gates Foundation, the aim is to identify opportunities for the wider integration of 3Rs approaches and recommend these for implementation by WHO through the Expert Committee on Biological Standardization (ECBS).

Regional workshops

We are hosting a series of regional workshops to better understand the potential impact of these changes on manufacturers and regulators globally. The output from these workshops will inform the recommendations we make to WHO and reduce the barriers for their implementation by ECBS. 

  • Europe – Wednesday 2 March 2022 (recordings available below)
  • Asia - Thursday 28 April 2022 (recordings available soon)
  • Pan-America – Monday 26 September 2022 (registration open shortly)
  • Africa and East Mediterranean – TBC

Europe: Wednesday 2 March 2022

The case for implementing the 3Rs in WHO guidelines

Professor Klaus Cichutek, Paul-Ehrlich-Institut, Germany and outgoing Chair of ECBS.

Webinar introduction, Professor Klaus Cichutek

How aligned are we across Europe?

Moderator: Dr Svein Rune Andersen, Norwegian Medicines Agency, Norway.

Panellists: Dr Emmanuelle Charton, EDQM, Dr Shahjahan Shaid, GSK, Dr Mark van Ooij, Janssen, Dr Anne Dybwad, Norwegian Medicines Agency, Norway, Dr Geneviève Waeterloos, Sciensano, Belgium, Dr Paul Stickings, NIBSC, UK.

Webinar title slide: Panel discussion